Explore the real-world limitations of GLP-1 therapies, including durability issues, lean mass preservation, and incomplete comorbidity coverage
Theyre most common during the early weeks of treatment or after a dose increase and tend to be mild to moderate in intensity
Along with access to GLP-1 medications, pharmaceutical manufacturers will also be providing a lifestyle support program at no additional cost to the state
Some data suggest GIP may promote adiposity under certain metabolic conditions
In addition to statistical significance (P-values), we quantified the effect size of group differences using the coefficient of determination (R2), which represents the proportion of variance in the outcome variable explained by the fixed effect
Both semaglutide and tirzepatide work through natural hormone pathways that influence appetite, fullness, and digestion not through stimulants or appetite suppressants